BCN(頭孢卡品前體酸)性質(zhì)、用途與生產(chǎn)工藝

用途

合成

頭孢卡品前體酸 (BCN) 是合成鹽酸頭孢卡品酯的重要中間體，以7-氨基頭孢烷酸為起始原料，經(jīng)水解反應得3-脫乙酰基-7-氨基頭孢烷酸，再與(Z)-2-(2-叔丁氧羰基氨基噻唑-4-基)-2-戊烯酸、二異丙胺作用得到頭孢卡品前體酸?？偸章?0%以上,純度98%以上。

BCN(頭孢卡品前體酸) 上下游產(chǎn)品信息

上游原料

下游產(chǎn)品

BCN(頭孢卡品前體酸) 生產(chǎn)廠家

153012-37-4, BCN(頭孢卡品前體酸) 相關(guān)搜索:

• API
• Sulfur & Selenium Compounds
• Pharmaceuticals
• Metabolites & Impurities
• Isotope Labelled Compounds
• Intermediates & Fine Chemicals
• Heterocycles
• Chiral Reagents
• 高純試劑
• 雜質(zhì)對照品
• 化工原料及中間體
• 化工中間體-化工原料
• 化學試劑
• 藥物雜質(zhì)及中間體
• 頭孢
• 醫(yī)藥原料
• 化學原藥
• 醫(yī)藥中間體
• C22H27N5O8S2C6H15N
• 頭孢卡品中間體(BCN)
• 頭孢卡品母核(BCN、頭孢卡品前體酸)
• BCN(純度≥98.0%)鹽酸頭孢卡品酯的中間體
• 5-Thia-1-氮雜雙環(huán)[4.2.0]10-2-烯-2-羧酸,3-[[(氨基羰基)氧基]甲基]-7-[(2Z)-2-[2-[[(1,1-二甲基乙氧基)羰基]氨基]-4-噻唑基]-1-氧代-2-戊烯-1-基]氨基]-8-氧代-,(6R,7R)-,Compd。用N-(1-甲基乙基)-2-丙氨酸(1:1)
• 頭孢卡品中間體
• 頭孢卡品異丙胺鹽
• 頭孢卡品前體酸/頭孢卡品異丙胺鹽/頭孢卡品二異丙胺鹽
• 頭孢卡品前體酸 BCN
• 頭孢卡品雜質(zhì)8
• 頭孢卡品前體二異丙胺鹽
• 頭孢卡品前體酸
• (6R,7R)-7-[[(Z)-2-(2-叔丁氧羰基氨基噻唑-4-基)-2-戊烯酰]氨基]-3-氨基甲酰氧甲基-8-氧代-5-硫雜-1-氮雜雙環(huán)[4.2.0]辛-2-烯-2-羧酸二異丙胺鹽
• 頭孢卡品前體
• BCN(頭孢卡品前體酸)
• 153012-37-4
• Cefcapene Impurity 5 Diisopropylamine
• Cefotaxime precursor acid
• Cephalosporin precursor acid
• [6R-[6alpha,7beta(Z)]]-3-[[(Aminocarbonyl)oxy]methyl]-7-[[2-[2-[[(1,1-dimethylethoxy)carbonyl]amino]-4-thiazolyl]-1-oxChemicalbooko-2-pentenyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacidcompd.withN-(1-methylethyl)-2-propanamine
• BPCM
• [6R-[6alpha,7beta(Z)]]-3-[[(Aminocarbonyl)oxy]methyl]-7-[[2-[2-[[(1,1-dimethylethoxy)carbonyl]amino]-4-thiazolyl]-1-oxo-2-pentenyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid compd. with N-(1-met
• [6R-[6alpha,7beta(Z)]]-3-[[(Aminocarbonyl)oxy]methyl]-7-[[2-[2-[[(1,1-di
• [6R-[6alpha,7beta(Z)]]-3-[[(Aminocarbonyl)oxy]methyl]-7-[[2-[2-[[(1,1-dimethylethoxy)carbonyl]amino]-4-thiazolyl]-1-oxChemicalbooko-2-pentenyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacidcompd.withN-(1-methylethyl)-2-propanamine USP/EP/BP
• BCN、BPCM
• (6R,7R)-7-[[(Z)-2-(2-t-Butoxycarbonylaminothiazol-4-yl)-2-pentenoyl]amino]-3-aminocarbonyl-oxymethyl-8-oxo-5-thia-1-azabicylo[4.2.0]oct-2-ene-2-carboxylic acid diisopropylamine salt
• Intermediate of Cefcapene
• [6R-[6alpha,7beta(Z)]]-3-[[(Amin
• Cefcapene Impurity 8
• (6R,7R)-7-[(Z)-2-(2-t-Butoxycarbonylaminothiazol-4-yl)pent-2-enoylamino]-3-carbamoyloxy -methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid diisopropylamine salt
• diisopropylamine 7-((2-(2-(2-(tert-butoxy)-2-oxoethyl)thiazol-4-yl)-1-oxidopent-2-en-1-ylidene)amino)-3-((iminooxidomethoxy)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
• precursor of cefcapene diisopropylanmine
• Cephalosporin diisopropylamine salt
• Boc-Cefcapene/BCN
• Cefcapene InterMediate
• Boc-Cefcapene
• Boc-Cefcapene.DIPA
• Precursor of cefcapene diisopropylanmine salt
• [6R-[6alpha,7beta(Z)]]-3-[[(Aminocarbonyl)oxy]methyl]-7-[[2-[2-[[(1,1-dimethylethoxy)carbonyl]amino]-4-thiazolyl]-1-oxo-2-pentenyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid compd. with N-(1-methylethyl)-2-propanamine
• N-Boc Cefcapene N,N-DiisopropylaMine